Hanall Biopharma's Chinese Partner Obtains Approval for Myasthenia Gravis Drug
Predicted impact: Low
Same drug approval already reported in the same group of items, partner-level news.
Comments
No comments yet. Start the conversation.
Comments are people's own views. Nothing here is financial advice.